IL313386A - TREATMENT USING HETERODIMERIC RELAXIN FUSIONS - Google Patents

TREATMENT USING HETERODIMERIC RELAXIN FUSIONS

Info

Publication number
IL313386A
IL313386A IL313386A IL31338624A IL313386A IL 313386 A IL313386 A IL 313386A IL 313386 A IL313386 A IL 313386A IL 31338624 A IL31338624 A IL 31338624A IL 313386 A IL313386 A IL 313386A
Authority
IL
Israel
Prior art keywords
relaxin
heterodimeric
fusions
treatment
relaxin fusions
Prior art date
Application number
IL313386A
Other languages
English (en)
Hebrew (he)
Inventor
Kathleen Marie Connolly
Anders Gabrielsen
Jr Richard Thomas George
Sami Ali Abdel Hafees Omar
Original Assignee
Medimmune Ltd
Kathleen Marie Connolly
Anders Gabrielsen
Jr Richard Thomas George
Sami Ali Abdel Hafees Omar
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Medimmune Ltd, Kathleen Marie Connolly, Anders Gabrielsen, Jr Richard Thomas George, Sami Ali Abdel Hafees Omar filed Critical Medimmune Ltd
Publication of IL313386A publication Critical patent/IL313386A/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22—Hormones
    • A61K38/2221—Relaxins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575—Hormones
    • C07K14/64—Relaxins
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/30—Non-immunoglobulin-derived peptide or protein having an immunoglobulin constant or Fc region, or a fragment thereof, attached thereto

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Cardiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Endocrinology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Hospice & Palliative Care (AREA)
  • Immunology (AREA)
  • Epidemiology (AREA)
  • Biochemistry (AREA)
  • Toxicology (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Pulmonology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Medicinal Preparation (AREA)
IL313386A 2021-12-15 2022-12-14 TREATMENT USING HETERODIMERIC RELAXIN FUSIONS IL313386A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US202163289687P 2021-12-15 2021-12-15
US202263386812P 2022-12-09 2022-12-09
PCT/EP2022/086001 WO2023111112A1 (en) 2021-12-15 2022-12-14 Treatment using heterodimeric relaxin fusions

Publications (1)

Publication Number Publication Date
IL313386A true IL313386A (en) 2024-08-01

Family

ID=84888900

Family Applications (1)

Application Number Title Priority Date Filing Date
IL313386A IL313386A (en) 2021-12-15 2022-12-14 TREATMENT USING HETERODIMERIC RELAXIN FUSIONS

Country Status (8)

Country Link
US (1) US20250295737A1 (https=)
EP (1) EP4447998A1 (https=)
JP (1) JP2024546877A (https=)
KR (1) KR20240121820A (https=)
AU (1) AU2022410335A1 (https=)
CA (1) CA3241355A1 (https=)
IL (1) IL313386A (https=)
WO (1) WO2023111112A1 (https=)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN118510536A (zh) 2021-11-11 2024-08-16 泰克托尼治疗股份有限公司 松弛素-2融合蛋白类似物及其使用方法
CN120813595A (zh) 2023-03-03 2025-10-17 阿斯利康(瑞典)有限公司 包含异源二聚体松弛素融合蛋白的药物制剂及其用途
AU2024270919A1 (en) 2023-05-18 2026-01-15 Tectonic Operating Company, Inc. Relaxin-2 fusion protein analogs and methods of using same

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7083784B2 (en) 2000-12-12 2006-08-01 Medimmune, Inc. Molecules with extended half-lives, compositions and uses thereof
ES2758994T3 (es) * 2010-11-05 2020-05-07 Zymeworks Inc Diseño anticuerpo heterodimérico estable con mutaciones en el dominio Fc
RU2014103288A (ru) 2011-07-01 2015-08-10 Байер Интеллектчуал Проперти Гмбх Слитые полипептиды релаксина и их применение
KR20140039257A (ko) * 2011-07-08 2014-04-01 바이엘 인텔렉쳐 프로퍼티 게엠베하 릴랙신을 방출하는 융합 단백질 및 이의 용도
EP3574004A1 (en) 2017-01-25 2019-12-04 Medimmune, LLC Relaxin fusion polypeptides and uses thereof
CN115768801A (zh) * 2020-05-08 2023-03-07 哈佛学院院长等 工程化松弛素及其使用方法

Also Published As

Publication number Publication date
US20250295737A1 (en) 2025-09-25
AU2022410335A1 (en) 2024-07-18
JP2024546877A (ja) 2024-12-26
CA3241355A1 (en) 2023-06-22
KR20240121820A (ko) 2024-08-09
EP4447998A1 (en) 2024-10-23
WO2023111112A1 (en) 2023-06-22

Similar Documents

Publication Publication Date Title
IL313386A (en) TREATMENT USING HETERODIMERIC RELAXIN FUSIONS
CA193741S (en) Skin massager
IL289464A (en) Relaxin analogs and methods of using them
CA196427S (en) Skin massager
CA193621S (en) Skin massager
IL275996A (en) Treatment using cytokine-encoded RNA
ZA201907552B (en) Recombinant human acid alpha-glucosidase
IL276170A (en) Lipid-adapted relaxin B peptide chains and their medical use
SI3297653T1 (sl) Zdravljenje postbariatrične hipoglikemije z antagonisti glp-1
IL292502A (en) Therapeutic methods using vadadustat
GB202005879D0 (en) Heterodimeric proteins
IL284133A (en) Variants of human alpha-galactosidase
MX2021003908A (es) Polipeptidos de accion prolongada y metodos para su produccion y administracion.
IL291618A (en) Heterodimeric proteins
HK40115426A (en) Treatment using heterodimeric relaxin fusions
IL321288A (en) Dosing regimens using fusions of relaxin heterodimers
GB201908076D0 (en) Skin treatment composition
IL290533A (en) spat
GB202115739D0 (en) Animal footbath
CA195264S (en) Foldable medical electrode
GB202106314D0 (en) Well stimulation using laser
GB201914492D0 (en) Skin Structure
GB201720099D0 (en) Tilapia Fish Skin